Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
BMC Health Serv Res ; 22(1): 166, 2022 Feb 09.
Article in English | MEDLINE | ID: mdl-35139847

ABSTRACT

BACKGROUND: The COVID-19 pandemic has a huge impact on healthcare provided. The nationwide pathology registry of the Netherlands, PALGA, offers an outstanding opportunity to measure this impact for diseases in which pathology examinations are involved. METHODS: Pathology specimen numbers in 2020 were compared with specimen numbers in 2019 for 5 periods of 4 weeks, representing two lockdowns and the periods in between, taking into account localization, procedure and benign versus malignant diagnosis. RESULTS: The largest decrease was seen during the first lockdown (spring 2020), when numbers of pathology reports declined up to 88% and almost all specimen types were affected. Afterwards each specimen type showed its own dynamics with a decrease during the second lockdown for some, while for others numbers remained relatively low during the whole year. Generally, for most tissue types resections, cytology and malignant diagnoses showed less decrease than biopsies and benign diagnoses. A significant but small catch-up (up to 17%) was seen for benign cervical cytology, benign resections of the lower gastro-intestinal tract, malignant skin resections and gallbladder resections. CONCLUSION: The COVID-19 pandemic has had a significant effect on pathology diagnostics in 2020. This effect was most pronounced during the first lockdown, diverse for different anatomical sites and for cytology compared with histology. The data presented here can help to assess the consequences on (public) health and provide a starting point in the discussion on how to make the best choices in times of scarce healthcare resources, considering the impact of both benign and malignant disease on quality of life.


Subject(s)
COVID-19 , Communicable Disease Control , Humans , Netherlands/epidemiology , Pandemics , Quality of Life , SARS-CoV-2
2.
Int J Law Psychiatry ; 60: 40-44, 2018.
Article in English | MEDLINE | ID: mdl-30217329

ABSTRACT

In Big Data health research, concerns have risen about privacy and data protection. While the ethical and legal discussion about these issues is ongoing, so is research practice. The aim of this qualitative case study is to gain more insight into how these concerns are currently dealt with in practice. For this multiple-case study, the YOUth cohort, a longitudinal cohort focusing on psychosocial development, and Big Data Psychiatry, a pilot study in Big Data analytics on psychiatric health data, were selected. A broad range of relevant documents were collected and semi-structured interviews with stakeholders were conducted. Data were coded, studied and divided into themes during an iterative analytical process. Three themes emerged: abandoning anonymisation, reconfiguring participant control, and the search for guidance and expertise. Overall, the findings show that it takes considerable effort to take privacy and data protection norms into account in a Big Data health research initiative, especially when individual participant level data need to be linked or enriched. By embracing the complexity of the law in an early phase, setbacks could be prevented, the existing flexibility within the law could be utilised, and systems or organisations could be designed and constructed to take relevant rules into account. Our paper illustrates that a close collaboration of experts with different backgrounds within the initiative may be necessary to be able to successfully navigate this process.


Subject(s)
Behavioral Research , Big Data , Confidentiality , Confidentiality/legislation & jurisprudence , Interviews as Topic , Organizational Case Studies , Pilot Projects , Psychiatry , Qualitative Research , Stakeholder Participation
3.
Diabetes Care ; 24(4): 705-9, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11315835

ABSTRACT

Neuropathy may bring about changes in form and function of the foot, which may lead to ulceration and progressive deformity. These manifestations often require specially adapted footwear. A comprehensive concept of the medical, functional, and technical requirements for this type of footwear is still lacking to date. In this article, We present an algorithm that should facilitate prescription and manufacture of adequate shoes. This algorithm attempts to establish a link between the requirements from a medical and functional point of view and the technical possibilities of orthopedic shoe technology.


Subject(s)
Algorithms , Diabetic Foot/prevention & control , Diabetic Neuropathies/therapy , Foot Deformities/therapy , Shoes , Amputation, Surgical , Diabetic Foot/physiopathology , Diabetic Foot/surgery , Diabetic Foot/therapy , Diabetic Neuropathies/physiopathology , Foot Deformities/rehabilitation , Humans , Joints/physiopathology , Prosthesis Design
SELECTION OF CITATIONS
SEARCH DETAIL
...